Major M&A deals this week include Viatris buys Pacira BioSciences, TowneBank acquires blueharbor

Analysts downgraded Voya, Pacira, Genworth, and more, with price-target changes for several.

Gainers Pacira BioSciences (NASDAQ:PCRX) shares moved upwards by 44.0% to $36.3 during Thursday&#39

Analysts downgraded STZ, TYL, DK, CRBU and PSX; price targets changed for STZ, TYL, DK and PSX.

U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 186.0% to $3.58 during Wednesda

U.S. stocks fell Wednesday, led by industrials. Crude inventories dropped unexpectedly, while Pengui

Analysts downgraded PJT, OPCH, CRBU, ABEV , cutting price targets for PJT, CRBU.

U.S. stocks fell Wednesday; Dow dropped 350 points. Energy rose, materials slid. Constellation beat

RBC Capital analyst Luca Issi downgrades Caribou Biosciences (NASDAQ:CRBU) from Outperform to Sec

U.S. stock futures were lower on Wednesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices fel

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 59.2% to $1.99 during Wednesday&

Leerink Partners analyst Daina Graybosch downgrades Caribou Biosciences (NASDAQ:CRBU) from Outper

U.S. stock futures fell; Constellation Brands dropped 5.1% despite beating estimates, while biotech,

Penguin Solutions jumped 7.7% after beating Q4 revenue/EPS estimates and issuing above-consensus FY2

Stocks in focus: Levi Strauss and Applied Digital report earnings; Caribou halts programs; Constella

Caribou Biosciences shares fall 35% after hours as the company weighs strategic alternatives and cut

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 64.0% to $2.05 during Tuesd

Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmace

-- Company to evaluate strategic alternatives to maximize stockholder value -- -- Caribou plans to d